MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Other Non Operating Income of -$8.6 million for Q4 2025, down 452.44% on a QoQ basis from -$1.6 million in Q3 2025, and down 55.64% year-over-year from -$19.4 million in Q4 2024.
MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Other Non Operating Income history runs 9 years deep, the most recent figure standing at -$8.6 million for Q4 2025.
- Quarterly Other Non Operating Income fell 55.64% year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 174.36% YoY) and the FY2025 annual result came in at $2.1 million, up 174.36% from the prior year.
- Other Non Operating Income was -$8.6 million for Q4 2025 at MeiraGTx Holdings, down from -$1.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $9.2 million in Q4 2023 and bottomed at -$12.8 million in Q3 2022.
- A 5-year average of -$1.5 million and a median of -$1.0 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income sank 2836.48% — and 2025, when it soared 3136.62%.
- MeiraGTx Holdings' Other Non Operating Income stood at $4.2 million in 2021, then tumbled by 341.65% to -$10.1 million in 2022, then jumped by 191.85% to $9.2 million in 2023, then tumbled by 159.8% to -$5.5 million in 2024, then tumbled by 55.64% to -$8.6 million in 2025.
- Business Quant data shows MGTX's Other Non Operating Income at -$8.6 million in Q4 2025, -$1.6 million in Q3 2025, and $8.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 996.53 Mn | 930.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.61 Mn |
| Sep 30, 2025 | -1.56 Mn |
| Jun 30, 2025 | 8.62 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | -284,000.00 |
| Mar 31, 2024 | -535,000.00 |
| Dec 31, 2023 | 9.25 Mn |
| Sep 30, 2023 | -8.68 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 3.86 Mn |
| Dec 31, 2022 | -10.07 Mn |
| Sep 30, 2022 | -12.84 Mn |
| Jun 30, 2022 | -10.43 Mn |
| Mar 31, 2022 | -2.65 Mn |
| Dec 31, 2021 | 4.17 Mn |
| Sep 30, 2021 | -3.37 Mn |
| Jun 30, 2021 | 381,000.00 |
| Mar 31, 2021 | -1.62 Mn |